Blueprint Medicines Corporation (BPMC) Social Stream
BLUEPRINT MEDICINES CORP (BPMC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BLUEPRINT MEDICINES CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 9 | $136 | $84 | $113.222 | $82.97 | 36.46% |
| 2021-11-10 | 9 | $136 | $84 | $114.444 | $82.97 | 37.93% |
| 2021-11-19 | 9 | $136 | $84 | $115.777 | $82.97 | 39.54% |
| 2021-11-29 | 9 | $139 | $84 | $115.888 | $82.97 | 39.67% |
| 2022-01-12 | 9 | $135 | $84 | $113.333 | $82.97 | 36.6% |
| 2022-01-25 | 9 | $135 | $84 | $110.555 | $82.97 | 33.25% |
| 2022-01-31 | 9 | $135 | $84 | $108.444 | $82.97 | 30.7% |
| 2022-02-08 | 9 | $135 | $84 | $104.777 | $82.97 | 26.28% |
| 2022-02-17 | 9 | $133 | $82 | $100.625 | $82.97 | 21.28% |
| 2022-03-01 | 10 | $133 | $71 | $97.333 | $82.97 | 17.31% |
| 2022-04-12 | 10 | $133 | $71 | $97.888 | $82.97 | 17.98% |
| 2022-04-28 | 10 | $133 | $68 | $97.555 | $82.97 | 17.58% |
| 2022-05-04 | 10 | $133 | $68 | $96.7 | $82.97 | 16.55% |
| 2022-05-18 | 10 | $152 | $65 | $100.272 | $82.97 | 20.85% |
| 2022-06-01 | 10 | $152 | $65 | $99.363 | $82.97 | 19.76% |
| 2022-06-10 | 10 | $152 | $41 | $96.909 | $82.97 | 16.8% |
| 2022-06-14 | 10 | $152 | $41 | $92.454 | $82.97 | 11.43% |
| 2022-07-27 | 12 | $152 | $40 | $86.461 | $82.97 | 4.21% |
| 2022-08-02 | 10 | $152 | $40 | $86.461 | $82.97 | 4.21% |
| 2022-08-03 | 13 | $152 | $40 | $86.23 | $82.97 | 3.93% |
| 2022-08-17 | 13 | $152 | $40 | $88.214 | $82.97 | 6.32% |
| 2022-08-18 | 13 | $152 | $40 | $87.285 | $82.97 | 5.2% |
| 2022-08-22 | 13 | $152 | $40 | $87.714 | $82.97 | 5.72% |
| 2022-09-06 | 13 | $152 | $40 | $88.428 | $82.97 | 6.58% |
| 2022-10-10 | 14 | $152 | $40 | $89.533 | $82.97 | 7.91% |
| 2022-10-26 | 14 | $152 | $40 | $89.8 | $82.97 | 8.23% |
| 2022-11-02 | 15 | $152 | $40 | $85.133 | $82.97 | 2.61% |
| 2022-11-04 | 16 | $115 | $40 | $78.733 | $82.97 | -5.11% |
| 2022-12-12 | 16 | $115 | $40 | $78.4 | $82.97 | -5.51% |
| 2022-12-14 | 17 | $115 | $40 | $77.25 | $82.97 | -6.89% |
| 2022-12-20 | 17 | $115 | $40 | $77.437 | $82.97 | -6.67% |
| 2023-01-23 | 17 | $115 | $41 | $76.937 | $82.97 | -7.27% |
| 2023-02-06 | 17 | $115 | $41 | $75.375 | $82.97 | -9.15% |
| 2023-02-10 | 17 | $115 | $41 | $75.062 | $82.97 | -9.53% |
| 2023-02-14 | 17 | $115 | $41 | $74.625 | $82.97 | -10.06% |
| 2023-02-17 | 17 | $114 | $41 | $69.812 | $82.97 | -15.86% |
| 2023-02-23 | 17 | $114 | $41 | $69.875 | $82.97 | -15.78% |
| 2023-02-27 | 17 | $114 | $38 | $69.25 | $82.97 | -16.54% |
| 2023-02-28 | 17 | $114 | $38 | $69.25 | $82.97 | -16.54% |
| 2023-03-28 | 17 | $114 | $38 | $69.5 | $82.97 | -16.23% |
| 2023-04-25 | 17 | $114 | $38 | $69.5 | $82.97 | -16.23% |
| 2023-05-05 | 17 | $114 | $41 | $70.2 | $82.97 | -15.39% |
| 2023-05-23 | 18 | $114 | $41 | $71.562 | $82.97 | -13.75% |
| 2023-05-24 | 18 | $114 | $41 | $72.437 | $82.97 | -12.69% |
| 2023-06-07 | 18 | $114 | $41 | $72.125 | $82.97 | -13.07% |
| 2023-06-14 | 17 | $114 | $43 | $74.666 | $82.97 | -10.01% |
| 2023-07-24 | 17 | $114 | $42 | $74.6 | $82.97 | -10.09% |
| 2023-07-26 | 17 | $114 | $42 | $74.866 | $82.97 | -9.77% |
| 2023-08-02 | 17 | $114 | $42 | $75.133 | $82.97 | -9.45% |
| 2023-08-17 | 17 | $114 | $40 | $75 | $82.97 | -9.61% |
| 2023-08-21 | 17 | $114 | $40 | $75.066 | $82.97 | -9.53% |
| 2023-10-25 | 17 | $114 | $40 | $74.4 | $82.97 | -10.33% |
| 2023-10-26 | 17 | $114 | $40 | $75.266 | $82.97 | -9.29% |
| 2023-10-27 | 17 | $114 | $50 | $77.25 | $82.97 | -6.89% |
| 2023-10-28 | 17 | $114 | $50 | $77.562 | $82.97 | -6.52% |
| 2023-12-11 | 17 | $114 | $50 | $76.125 | $82.97 | -8.25% |
| 2023-12-12 | 17 | $114 | $50 | $77.375 | $82.97 | -6.74% |
| 2023-12-19 | 17 | $115 | $50 | $80.812 | $82.97 | -2.6% |
| 2023-12-22 | 18 | $115 | $50 | $81.941 | $82.97 | -1.24% |
The Trend in the Analyst Price Target
Over the past 43 months, BPMC's average price target has gone down $8.13.
Over the past 48 weeks, BPMC's average upside potential has been 37.79%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-06 | 17 | 115 | 41 | 75.375 | 45.67 | 65.04% |
| 2023-03-21 | 17 | 114 | 38 | 69.500 | 45.52 | 52.68% |
| 2023-03-30 | 17 | 114 | 38 | 69.500 | 44.29 | 56.92% |
| 2023-06-07 | 17 | 114 | 43 | 74.200 | 60.03 | 23.6% |
| 2023-12-11 | 17 | 114 | 50 | 76.647 | 80.99 | -5.36% |
BPMC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.83 | 12 | 1 | 3 | 2 | 2 | 18 |
The Trend in the Broker Recommendations
BPMC's average broker recommendation rating improved by 0.29 over the prior 16 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how BLUEPRINT MEDICINES CORP fares relative to all US stocks, note that its variance in analysts' estimates is lower than -5681.3% of that group.
- BLUEPRINT MEDICINES CORP's number of analysts covering the stock is higher than 6111.78% of stocks in the mid market cap category.
- BPMC has a higher upside potential (average analyst target price relative to current price) than 1031.46% of Pharmaceutical Products stocks.
- BPMC has a higher average analyst price target than 5759.08% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BLUEPRINT MEDICINES CORP are QURE, XNCR, and PAHC.
View All Top Stocks by Price Target
Is BPMC a Buy, Hold or Sell? See the POWR Ratings now!